|
Safinamide
Theoretical analysis:Safinamide
MF: C17H19FN2O2
MW: 302.347
CAS: 133865-89-1
Availability and price:Safinamide更多>>
|
|
|
Bepotastine
Theoretical analysis:Bepotastine
MF: C21H25ClN2O3
MW: 388.89
CAS: 190786-43-7
Availability and price:Bepotastine
更多>>
|
|
|
Duloxetine
Theoretical analysis:Duloxetine
MF: C18H19NOS
MW: 297.41
CAS: 116539-59-4
Availability and price:Duloxetine
更多>>
|
|
|
Fidarestat
Theoretical analysis:Fidarestat
MF: C12H10FN3O4
MW: 279.22
CAS: 136087-85-9
Availability and price:Fidarestat更多>>
|
|
|
Darbufelone
Theoretical analysis:Darbufelone
MF: C18H24N2O2S
MW: 332.46036
CAS: 139226-28-1
Availability and price:Darbufelo...
更多>>
|
|
|
Ethirimol
Theoretical analysis:Ethirimol
MF: C11H19N3O
MW: 209.29
CAS: 23947-60-6
Availability and price:Ethirimol
...
更多>>
|
|
|
Retigabine
Theoretical analysis:Retigabine
MF: C16H18FN3O2
MW: 303.3314232
CAS: 150812-12-7
Availability and price:Retigabi...
更多>>
|
|
|
Tiletamine
Theoretical analysis:Tiletamine
MF: C12H17NOS
CAS: 14176-49-9
Availability and price:Tiletamine
Pakag...
更多>>
|
|
|
LY2940680(Taladegib)
Description of:LY2940680
M.Wt: 512.5
Formula: C26H24F4N6O
Solubility: Unknown
Purity: 98%
Storage: at -20℃ 2 years<...
更多>>
|
|
|
LY2886721
Description of:LY2886721
LY2886721 is a novel potent agent that is used to treat Alzheimer’s Disease in preclinical experiments. 更多>>
|
|